Abstract
We report on the synthesis, functionalization, and structural characterization of 11 novel dimethylarsinate-functionalized arsenomolybdates(V), [RAsMoV 6O15(OH)3{AsO2(CH3)2}3]2– (R = HO, CH3, C2H5, C6H5, 3,5-(HOOC)2C6H3, 4-FC6H4, 4-F3CC6H4, 4-F3COC6H4, 4-BrC6H4, and 4-N3C6H4) and [AsIIIMoV 6O15(OH)3{AsO2(CH3)2}3]3–, featuring a reduced hexanuclear {MoV 6O24} core, peripherally coordinated by three dimethylarsinate ligands and centrally functionalized with diverse organoarsonate, arsenate, or arsenite groups, including carboxylated, fluorinated, brominated, and azido derivatives. Synthesized via a simple one-pot aqueous method, the compounds were thoroughly characterized by single-crystal X-ray diffraction, thermogravimetric analysis, and elemental analysis in the solid state. Solution-phase stability was assessed by multinuclear (1H, 13C, and 19F) nuclear magnetic resonance, while gas-phase behavior and fragmentation pathways were probed through electrospray ionization mass spectrometry, and tandem mass spectrometry (collision-induced dissociation). Antibacterial screening against Escherichia coli, Bacillus subtilis, and three pathogenic bacterial strains Listeria monocytogenes, Salmonella enterica, and Vibrio parahaemolyticus revealed that three of the 11 polyanions exhibit moderate antibacterial activity. Additionally, the synthesis of 3,5-bis(carboxy)phenylarsonic acid, 3,5-(HOOC)2C6H3AsO3H2, is reported here for the first time.


Introduction
Polyoxometalates (POMs) are a class of discrete, anionic polynuclear metal oxide clusters composed of early transition metals in high oxidation states (M = WVI, MoVI, VV, NbV, and TaV), known for their broad applications in photo/electrocatalysis, medicine, magnetism, and energy storage/conversion. POMs offer significant potential for structural and functional modification, as the covalent integration of organic or organometallic moieties into their frameworks enables precise control over molecular properties such as shape, size, solubility, lipophilicity, stability, toxicity, redox, and acid–base behavior, thereby facilitating the rational design of advanced inorganic–organic hybrid materials with tailored functionalities for diverse applications.
Building on this structural versatility, we recently reported a series of reduced dimethylarsinate-functionalized, hexanuclear phosphomolybdenum clusters with the general formula [RPMoV 6O15(OH)3{AsO2(CH3)2}3]2– (R = H, HO, CH3, HO2CCH2, HO2CC2H4, C6H5, 4-FC6H4, and 4-F3COC6H4), characterized by a cyclic {Mo6 VO24} core, flanked by dimethylarsinate ligands and central organophosphonate substitutions. This system was extensively studied in solid, solution, and gas phases, with ESI-MS confirming the coexistence of monomeric and dimeric species. Ion mobility mass spectrometry further enabled the separation of both entities, allowing for the acquisition of clean spectra for each. Haushalter and Lai originally isolated this hexanuclear molybdic wheel archetype as the reduced molybdenum phosphate, {P4MoV 6}, where peripheral phosphates and hydroxo bridges connect {MoV 2O4} dimers. Subsequent structural analogues, such as {(C6H5P)4MoV 6}, − {(C6H5As)4MoV 6}, and thiomolybdate variants {X4MoV 6S6O6} (X = HPO4 or HAsO4), have further highlighted the framework’s adaptability. Additionally, reactions of reduced MoV systems with methylenebisphosphonates and various structure-directing agents yielded cyclic compounds, {(MoV 2O4)(O3PCH2PO3)} n (n = 3, 4, or 10}, encapsulating additional ligands such as MoO4 2–, SO3 2–, CO3 2–, O3PCH2PO3 4–, and CH3AsO3 2–.
Organoarsenic chemistry, although it has progressed more slowly than organophosphorus chemistry, boasts a rich history, dating back to 1760, when Cadet de Gassicourt synthesized cacodyl ((CH3)2AsAs(CH3)2), the first known organometallic compound. This slower development, partly due to toxicity concerns, contrasts with the rapid progress in organophosphorus chemistry, driven by 31P NMR spectroscopy as well as its well-documented reactivity and electronic characteristics. In the realm of POM chemistry, initial pivotal contributions to organoarsonate-functionalized POMs were made by Pope’s group, which reported tetramolybdobisarsonate complexes, [R2AsMo4O15H]2– (R = CH3, C2H5, or C6H5), a system initially proposed by Rosenheim and Bilecki, and cyclic, hexamolybdobisarsonate complexes, [(RAs)2Mo6O24]4– (R = CH3, C6H5, or p-C6H4NH2). Further advancements involved Matsumoto’s synthesis of [(C6H5As)2Mo6O24(H2O)]4– and Liu et al.’s contributions with the pentamolybdate [(n-C3H7As)2Mo5O21]4– and hexamolybdate [(n-C3H7As)2Mo6O24]4– frameworks. Moreover, Kortz’s group expanded this family of organoarsonate-containing hexamolybdates by integrating para-substituted phenyl derivatives (R = 4-BrC6H4, 4-N3C6H4, 4-FC6H4, 4-F3CC6H4, or 4-F3COC6H4). Beyond these, dual-site functionalization has also been realized. In one such example, a hexamolybdic wheel is centrally occupied by lone pair-containing heteroatoms and surrounded peripherally by amino acids bound via their carboxylate groups as in [AsIIIMo6O21(O2CRNH3)3]3– (R = CH2, C2H4, or C3H6).
POMs are recognized as potent metallodrugs with promising antimicrobial, antiviral, and antitumor properties. In particular, hybrid POM systems, formed by integrating electron-rich POM cores into bioactive frameworks, have emerged as strong candidates for biomedical research. With antibiotic resistance becoming a global health crisis, the development of novel antimicrobial agents is of paramount importance. Halogenated compounds, especially fluoro-pharmaceuticals, are widely employed in contemporary medicinal chemistry; thus, the strategic introduction of biologically active halogen substituents, such as fluoro or bromo, at the para position of phenylarsonate rings in polyoxomolybdates represents a promising approach. Such hybrid frameworks not only enhance stability under physiological conditions but also offer tailored bioactivity via modulation of their organic constituents. Notably, Kortz’s group has shown previously that {PhSbIII}-incorporated polyoxotungstates exhibit enhanced antibacterial and antitumor effects, underlining the therapeutic potential of functionalized POMs.
Expanding on our prior work with reduced molybdate systems in the presence of cacodylate and phosphonates under aqueous, reducing conditions, we now report the substitution of phosphonates with arsonates. This modification yielded a series of reduced, dimethylarsinate-functionalized arsenomolybdates(V), [RAsMoV 6O15(OH)3{AsO2(CH3)2}3]2– and [AsIIIMoV 6O15(OH)3{AsO2(CH3)2}3]3–. These structures incorporate a variety of organoarsonates (RAsO3 2–), arsenate, and arsenite as structure-directing agents. Given the increasing utility of ESI-MS for characterizing the intricate structures of complex inorganic POM clusters, with numerous gas-phase fragmentation studies of POMs being investigated using CID MS/MS, we undertook a detailed mass spectrometric analysis to elucidate the fragmentation behavior of these novel arsenomolybdate species. Furthermore, recognizing both their structural novelty and the rising interest in bioactive POMs, we carried out preliminary studies to assess the biological activity of these arsenomolybdates.
Experimental Section
Materials and Physical Measurements
The precursors ethylarsonic acid, C2H5AsO3H2, (4-fluorophenyl)arsonic acid, (4-FC6H4)AsO3H2, (4-trifluoromethylphenyl)arsonic acid, (4-F3CC6H4)AsO3H2, (4-trifluoromethoxyphenyl)arsonic acid, (4-F3COC6H4)AsO3H2, (4-bromophenyl)arsonic acid, (4-BrC6H4)AsO3H2, and (4-azidophenyl)arsonic acid, (4-N3C6H4)AsO3H2, were synthesized following published literature procedures and characterized using infrared (IR) and nuclear magnetic resonance (NMR) spectroscopy. The precursor 3,5-bis(carboxy)phenylarsonic acid, (3,5-(HOOC)2C6H3AsO3H2), is reported and characterized here for the first time. All other reagents were purchased from commercial sources and used as received without further purification.
The elemental analyses were performed by Zentrallabor, Technische Universität Hamburg (TUHH), Am Schwarzenberg-Campus 1, 21073 Hamburg (Na, Mo, and As), and Analytische Laboratorien, Industriepark Kaiserau (Haus Heidbruch), 51789 Lindlar, Germany (C, H, N, F, and Br). The sodium content was further verified in-house by atomic absorption (AA) spectroscopy on a Varian SpectrAA 220 AA spectrometer. The FT-IR spectra were recorded on KBr pellets using a Nicolet Avatar 370 spectrophotometer operating in the 400–4000 cm–1 range with 32 scans and a 4 cm–1 resolution. The peak intensities are abbreviated as follows: w, weak; m, medium; s, strong; sh, shoulder. The crystal water content was analyzed via thermogravimetric analysis (TGA) on a TA Instrument SDT Q600 ramped from room temperature to 600 °C at a heating rate of 5 °C min–1 under a N2 flow of 10 mL min–1. Multinuclear solution NMR spectra (1H, 13C{H}, and 19F) were recorded at room temperature on a JEOL ECS 400 MHz spectrometer using 5 mm probes, tuned to respective resonance frequencies of 399.78 MHz (1H), 100.52 MHz (13C{H}), and 376.17 MHz (19F). The chemical shifts were referenced to tetramethylsilane (1H and 13C{H}) and CFCl3 (19F). Acquisition of the 13C{H} NMR spectra for the polyanions required an overnight run. For assignments of the 1H and 13C NMR resonances, see numbering schemes in the SI. Ultraviolet–visible (UV–vis) studies were conducted using a Varian Cary 100 Bio UV–vis spectrophotometer over the 200–800 nm range, using 1 cm quartz cuvettes.
High-resolution mass spectra were recorded using a Bruker Daltonics QTOF Impact HD mass spectrometer employing both negative and positive electrospray ionization modes. The QTOF Impact mass spectrometer (Bruker Daltonics) was fitted with an ESI source, and external calibration was achieved with 10 mL of 0.1 M sodium formate solution. The instrument ion source and tubing were rinsed with methanol. Calibration was carried out using the enhanced quadratic calibration mode. All MS measurements were performed in both negative and positive ion modes. Samples were measured as direct infusions at a concentration of 10 μg/mL in deionized water at a flow rate of 180 μL/min. Samples were prepared by dissolving 1 mg of POM in 1 mL of deionized water followed by a 1:100 dilution. Spectral simulations were carried out in Data Analysis 4.1 (Bruker Daltonics, Bremen). For tandem MS measurements, POM precursor ions were isolated with an isolation window of 20 Da and fragmented by CID if necessary, with an increase in collision energy until the disappearance of the precursor ion.
Synthetic Procedures
Synthesis of 3,5-Bis(carboxy)phenylarsonic Acid, 3,5-(HOOC)2C6H3AsO3H2
Dimethyl 5-aminoisophtalate (4.18 g, 20.0 mmol) was dissolved in 22 mL of H2O, acidified with 5 mL of conc. HCl, and cooled to 0 °C in an ice bath. After stirring for 15 min, a cold aqueous solution of NaNO2 (1.45 g, 21.0 mmol, in 5 mL H2O) was added dropwise. Separately, a mixture of As2O3 (2.50 g, 12.6 mmol) and Na2CO3 (5.30 g, 33.1 mmol) was dissolved in 25 mL of hot water and stirred for 20 min, followed by the addition of CuSO4·5H2O (0.11 g, 21.7 mmol). The solution was heated until boiling for another 15 min. Upon cooling, 5 mL of diethyl ether was added to form an organic layer on the liquid. Then, the former solution was added dropwise under stirring for 1 h in an ice bath. The resulting mixture was then filtered and acidified to pH 6, filtered again, and finally acidified to pH 1 before a final filtration. The volume of the solution was reduced to one-third, and the mixture was refrigerated to induce precipitation. The resulting off-white solid, 3,5-bis(methoxycarbonyl)phenylarsonic acid, was washed with diluted HCl and collected for further analysis. Yield: 1.2 g (19%). FT-IR (KBr pellet, ν/cm–1): 3444 (m), 2957 (m), 2336 (m), 1736 (s), 1444 (m), 1277 (s), 1144 (w), 1112 (w), 998 (m), 916 (s), 849 (w), 803 (m), 751 (m), 671 (w), 495 (w) (Figure S1). 1H NMR (DMSO-d 6, ppm): δ 3.9 (s, 6H, CH 3), 8.4 (s, 2H, ortho-C6 H 3), 8.6 (s, 1H, para-C6 H 3). 13C{1H} NMR (DMSO-d 6, ppm): δ 54.0 (CH3), 132.1 (C-2), 134.0 (C-1), 135.4 (C-3), 136.8 (C-4), 165.4 (COOCH3) (Figure S2).
3,5-Bis(methoxycarbonyl)phenylarsonic acid (1.2 g) was dissolved in 14 mL of water, followed by the addition of 7 mL of concentrated HCl. The solution was refluxed for 24 h at 105 °C. After cooling, the solvent was evaporated under vacuum, and the resulting white precipitate of 3,5-bis(carboxy)phenylarsonic acid, 3,5-(HOOC)2C6H3AsO3H2, was air-dried for 1 day. Yield: 0.7 g (64%). FT-IR (KBr pellet, ν/cm–1): 3460 (m), 3174 (m), 3097 (m), 2325 (m), 1881 (m), 1725 (s), 1668 (m), 1603 (m), 1453 (w), 1322 (m), 1293 (s), 1238 (s), 1194 (s), 1161 (s), 1118 (s), 994 (w), 881 (s), 821 (m), 799 (s), 776 (m), 712 (w), 668 (s), 518 (w), 486 (w), 433 (w) (Figure S1). 1H NMR (DMSO-d 6, ppm): δ 8.4 (s, 2H, ortho-C6 H 3), 8.6 (s, 1H, para-C6 H 3). 13C{1H} NMR (DMSO-d 6, ppm): δ 132.9 (C-2), 134.1 (C-1), 134.9 (C-3), 135.8 (C-4), 166.0 (COOH) (Figure S3).
Synthesis of Na2.5(NH4)0.5[AsIIIMoV 6O15(OH)3{AsO2(CH3)2}3]·11H2O (NaNH4–AsIIIMo6 )
Na2MoO4·2H2O (0.024 g, 0.10 mmol), N2H4·2HCl (0.011 g, 0.10 mmol), and arsenic trioxide, As2O3 (0.01 g, 0.05 mmol) were dissolved in 2 mL of 1 M sodium dimethylarsinate buffer (1 M aqueous solution of dimethylarsinic acid (pH 4) adjusted to pH 7 by adding NaOH pellets). The resulting mixture was stirred and heated at 80 °C for 1 h in a sealed vial. Dark-red, hexagonal crystals (Figure S4a) gradually formed over 2 weeks as the reaction mixture cooled. The crystals were then filtered and air-dried. Isolated yield: 0.017 g (63% based on Mo). Elemental analysis (%) calcd (found) for NaNH4–AsIIIMo6 : Na, 3.55 (3.85); Mo, 35.6 (35.8); As, 18.5 (19.3); C, 4.46 (4.49); H, 2.80 (3.27); N, 0.43 (0.62). FT-IR (2% KBr pellet, ν/cm–1): 3430 (s) [ν(O–H)], 2997 (w), 2927 (w) [ν(C–H)], 1643 (s) [δ(O–H)], 1410 (m) [δ(C–H)], 1276 (m) [ν(As–C)], 1032 (m), 938 (s) [ν(MoO)], 856 (s) [ν(As–O)], 753 (s), 622 (s), 493 (s), 428 (s) [δ(Mo–O(Mo))] (Figure S5a). 1H NMR (H2O/D2O, ppm): δ 1.6 (s, 3H, (CH 3)2AsO2), 2.0 (s, 3H, (CH 3)2AsO2) (Figure a). 13C{1H} NMR (H2O/D2O, ppm): δ 17.9 ((CH3)2AsO2), 19.4 ((CH3)2AsO2) (Figure b).
2.
Multinuclear NMR study: (a) 1H and (b) 13C{1H} NMR spectra of NaNH4-AsIIIMo6 (red) and NaNH4-AsVMo6 (blue), dissolved in H2O/D2O at room temperature. The spectra of the reference compounds, i.e., cacodylic acid (H-Cac, pH 4.10) and sodium cacodylate (Na-Cac, pH 6.0) buffer, are shown in black.
Synthesis of Na1.5(NH4)0.5[HOAsMoV 6O15(OH)3{AsO2(CH3)2}3]·0.6NH4Cl·10H2O (NaNH4–AsVMo6 )
(NH4)6Mo7O24·4H2O (0.265 g, 0.215 mmol) and N2H4·2HCl (0.052 g, 0.500 mmol) were completely dissolved in 10 mL of 0.5 M sodium dimethylarsinate buffer (pH 7). Following this, disodium hydrogen arsenate heptahydrate, Na2HAsO4·7H2O (0.078 g, 0.250 mmol), was added to the mixture and the pH was gradually adjusted to 6.8–6.9 by the dropwise addition of 6 M NaOH solution. The resulting dark-red solution was heated at 80 °C for 1 h. After 3 weeks of cooling at room temperature, dark-red, block-shaped crystals (Figure S4b) formed, which were collected and air-dried. Isolated yield: 0.06 g (15% based on Mo). Elemental analysis (%) calcd (found) for NaNH4–AsVMo6 : Na, 2.12 (2.46); Mo, 35.4 (34.9); As, 18.4 (18.0); C, 4.43 (4.48); H, 2.88 (2.95); N, 0.95 (1.19). FT-IR (2% KBr pellet, ν/cm–1): 3397 (s), 3220 (s) [ν(N–H), ν(O–H)], 3014 (w), 2924 (w) [ν(C–H)], 1630 (m) [δ(O–H)], 1402 (m) [δ(C–H)], 1271 (w) [ν(As–C)], 966 (s), 921 (w) [ν(MoO)], 822 (s) [ν(As–O)], 746 (m), 654 (w), 527 (w), 494 (m), 457 (m) [δ(Mo–O(Mo))] (Figure S5b). 1H NMR (H2O/D2O, ppm): δ 1.9 (s, 3H, (CH 3)2AsO2), 2.2 (s, 3H, (CH 3)2AsO2) (Figure a). 13C{1H} NMR (H2O/D2O, ppm): δ 18.7 ((CH3)2AsO2), 18.9 ((CH3)2AsO2) (Figure b).
Synthesis of NaNH4[CH3AsMoV 6O15(OH)3{AsO2(CH3)2}3]·10H2O (NaNH4–CH3AsMo6 )
(NH4)6Mo7O24·4H2O (0.053 g, 0.04 mmol), N2H4·2HCl (0.011 g, 0.10 mmol), and disodium methylarsonate, CH3AsO3Na2 (0.009 g, 0.05 mmol), were added to 2 mL of 0.5 M sodium dimethylarsinate buffer (pH 7). The resulting mixture was stirred and heated at 80 °C for 1 h. Dark-red, block-shaped crystals started appearing after 1 day as the solution cooled to room temperature. Isolated yield: 0.030 g (40% based on Mo). Elemental analysis (%) calcd (found) for NaNH4–CH3AsMo6 : Na, 1.45 (1.22); Mo, 36.2 (35.5); As, 18.9 (19.1); C, 5.29 (5.41); H, 3.05 (3.17); N, 0.88 (1.07). FT-IR (2% KBr pellet, ν/cm–1): 3416 (s), 3202 (s) [ν(N–H), ν(O–H)], 3017 (w), 2925 (w) [ν(C–H)], 1625 (s) [δ(O–H)], 1477 (w), 1442 (w), 1403 (m) [δ(C–H)], 1275 (w) [ν(As–C)], 968 (s), 936 (w) [ν(MoO)], 822 (s) [ν(As–O)], 748 (m), 656 (w), 521 (w), 493 (m), 459 (m) [δ(Mo–O(Mo))] (Figure S5c). 1H NMR (H2O/D2O, ppm): δ 0.96 (s, 3H, CH 3AsO3), 1.9 (s, 9H, (CH 3)2AsO2), and 2.2 (s, 9H, (CH 3)2AsO2) (Figure S20a). 13C{1H} NMR (H2O/D2O, ppm): δ 18.0 ((CH3)2AsO2), 18.9 (CH3AsO3), 19.7 ((CH3)2AsO2) (Figure S20b).
Synthesis of Na1.5(NH4)0.5[C2H5AsMoV 6O15(OH)3{AsO2(CH3)2}3]·10H2O (NaNH4–C2H5AsMo6 )
The polyanion C2H5AsMo6 was synthesized following the same procedure as for AsIIIMo6 , except that ethylarsonic acid, C2H5AsO3H2 (0.008 g, 0.05 mmol), was used instead of As2O3. The reaction mixture (pH 7) was heated at 80 °C for 1 h in a sealed vial. Upon cooling to room temperature, red crystals (Figure S4c) began forming within a day. Isolated yield: 0.015 g (56% based on Mo). Elemental analysis (%) calcd (found) for NaNH4–C2H5AsMo6 : Na, 2.2 (2.4); Mo, 35.9 (36.3); As, 18.7 (19.8); C, 5.99 (6.16); H, 3.01 (3.30); N, 0.44 (0.49). FT-IR (2% KBr pellet, ν/cm–1): 3401 (s) [ν(O–H)], 3014 (w), 2926(w) [ν(C–H)], 1636 (m) [δ(O–H)], 1456 (w), 1406 (m) [δ(C–H)], 1274 (m) [ν(As–C)], 968 (s), 918 (w) [ν(MoO)], 824 (s) [ν(As–O)], 747 (m), 655 (w), 615 (w), 493 (m), 459 (m) [δ(Mo–O(Mo))] (Figure S5d). 1H NMR (H2O/D2O, ppm): δ 0.57 (t, 3H, 3 J HH = 8 Hz, CH 3CH2AsO3), 1.21 (q, 2H, 3 J HH = 8 Hz, CH3CH 2AsO3), 1.9 (s, 9H, (CH 3)2AsO2), 2.3 (s, 9H, (CH 3)2AsO2) (Figure S22).
Synthesis of NaNH4[C6H5AsMoV 6O15(OH)3{AsO2(CH3)2}3]·10H2O (NaNH4–C6H5AsMo6 )
The polyanion C6H5AsMo6 was synthesized by dissolving (NH4)6Mo7O24·4H2O (0.053 g, 0.04 mmol), N2H4·2HCl (0.011 g, 0.10 mmol), and phenylarsonic acid, C6H5AsO3H2 (0.01 g, 0.05 mmol) in 2 mL of 0.5 M sodium dimethylarsinate buffer (pH 7). The reaction mixture was stirred and heated at 80 °C for 1 h. Red block-shaped crystals formed within a day upon cooling to room temperature. Isolated yield: 0.025 g (32% based on Mo). Elemental analysis (%) calcd (found) for NaNH4–C6H5AsMo6 : Na, 1.39 (1.15); Mo, 34.9 (34.4); As, 18.2 (18.5); C, 8.73 (9.04); H, 3.05 (3.21); N, 0.85 (1.07). FT-IR (2% KBr pellet, ν/cm–1): 3410 (s) [ν(N–H), ν(O–H)], 3014 (w), 2927 (w) [ν(C–H)], 1623 (m) [δ(O–H)], 1444 (w), 1401 (m) [δ(C–H)], 1274 (w) [ν(As–C)], 1097 (w), 969 (s), 939 (w), 912 (w) [ν(MoO)], 826 (s) [ν(As–O)], 746 (s), 692 (w), 655 (w), 612 (w), 524 (w), 493 (m), 458 (m) [δ(Mo–O(Mo))] (Figure S5e). 1H NMR (H2O/D2O, ppm): δ 1.6 (s, 9H, (CH 3)2AsO2), 2.3 (s, 9H, (CH 3)2AsO2), 7.07 (d, 2H, 3 J HH = 8 Hz, ortho-C6 H 5), 7.37 (t, 2H, 3JHH = 8 Hz, meta-C6 H 5), 7.46 (t, 1H, 3 J HH = 8 Hz, para-C6 H 5). 13C{1H} NMR (H2O/D2O, ppm): δ 17.8 ((CH3)2AsO2), 19.5 ((CH3)2AsO2), 129.4 (C-3), 129.7 (C-2), 131.2 (C-4), 133.6 (C-1) (Figure S23).
High-quality single crystals of Na–C6H5AsMo6 suitable for single-crystal XRD were obtained by heating Na2MoO4·2H2O (0.024 g, 0.10 mmol), N2H4·2HCl (0.011 g, 0.10 mmol), and phenylarsonic acid, C6H5AsO3H2 (0.01 g, 0.05 mmol), in 2 mL, 1 M sodium dimethylarsinate buffer (pH 7) at 80 °C for 1 h. The resulting product was characterized via IR spectroscopy (Figure S6).
Synthesis of NaNH4[4-FC6H4AsMoV 6O15(OH)3{AsO2(CH3)2}3]·7H2O (NaNH4–FC6H4AsMo6 )
The polyanion 4-FC6H4AsMo6 is synthesized in the same way as C6H5AsMo6 by adding (4-fluorophenyl)arsonic acid, 4-FC6H4AsO3H2 (0.011 g, 0.05 mmol), instead of C6H5AsO3H2. The reaction mixture (pH 6.7–6.8) was stirred and heated at 80 °C for 1 h. Dark-red, block-shaped crystals started appearing after 2 days as the solution cooled to room temperature. Isolated yield: 0.067 g (89% based on Mo). Elemental analysis (%) calcd (found) for NaNH4–FC6H4AsMo6 : Na, 1.42 (1.54); Mo, 35.6 (36.1); As, 18.6 (19.1); F, 1.18 (1.02); C, 8.92 (8.37); H, 2.68 (2.77); N, 0.87 (1.03). FT-IR (2% KBr pellet, ν/cm–1): 3403 (s), 3214 (s) [ν(N–H), ν(O–H)], 3017 (w), 2920 (w) [ν(C–H)], 1631 (m) [δ(O–H)], 1591 (sh), 1496 (w) [ν(C = C)], 1403 (m) [δ(C–H)], 1273 (w) [ν(As–C)], 1232 (w), 1164 (w), 1095 (w) [ν(C–F)], 968 (s), 918 (w) [ν(MoO)], 843 (s) [ν(As–O)], 743 (m), 655 (w), 586 (w), 492 (m), 460 (m) [δ(Mo–O(Mo))] (Figure S7a). 1H NMR (H2O/D2O, ppm): δ 1.6 (s, 9H, (CH 3)2AsO2), 2.3 (s, 9H, (CH 3)2AsO2), 7.06 (m, 4H, C6 H 4) (Figure S25). 13C{1H} NMR (H2O/D2O, ppm): δ 17.9 ((CH3)2AsO2), 19.7 ((CH3)2AsO2), 116.9 (d, 2 J CF = 22.14 Hz, C-3), 127.2 (s, C-1), 132.5 (d, 3 J CF = 8.44 Hz, C-2), 165.7 (d, 1 J CF = 261.35 Hz, C-4). 19F NMR (H2O/D2O, ppm): δ −104.5 (Figure S26).
Synthesis of NaNH4[4-F3CC6H4AsMoV 6O15(OH)3{AsO2(CH3)2}3]·11H2O (NaNH4–F3CC6H4AsMo6 )
The polyanion 4-F3CC6H4AsMo6 is prepared like C6H5AsMo6 by replacing C6H5AsO3H2 with (4- trifluoromethylphenyl)arsonic acid, 4-F3CC6H4AsO3H2 (0.013 g, 0.05 mmol). The reaction mixture (pH 6.7–6.8) was stirred and heated at 80 °C for 1 h. The total isolated yield of red, block-shaped crystals after 2 days is 0.07 g (86% based on Mo). Elemental analysis (%) calcd (found) for NaNH4–F3CC6H4AsMo6 : Na, 1.32 (1.13); Mo, 33.1 (32.9); As, 17.2 (17.6); F, 3.28 (3.45); C, 8.99 (8.41); H, 2.96 (2.79); N, 0.81 (1.24). FT-IR (2% KBr pellet, ν/cm–1): 3418 (s), 3199 (s) [ν(N–H), ν(O–H)], 3017(w), 2928 (w) [ν(C–H)], 1636 (s) [δ(O–H)], 1402 (s) [δ(C–H)], 1326 (s), 1273 (w) [ν(As–C)], 1173 (m), 1132 (m), 1060 (m) [ν(C–F)], 1012 (sh), 969 (m), 924 (w) [ν(MoO)], 844 (s) [ν(As–O)], 744 (m), 655 (w), 590 (m), 494 (m), 465 (m) [δ(Mo–O(Mo))] (Figure S7b). 1H NMR (H2O/D2O, ppm): δ 1.6 (s, 9H, (CH 3)2AsO2), 2.3 (s, 9H, (CH 3)2AsO2), 7.18 (d, 2H, 3JHH = 8 Hz, ortho-C6 H 4), 7.67 (d, 2H, 3 J HH = 8 Hz, meta-C6 H 4) (Figure S27). 13C{1H} NMR (H2O/D2O, ppm): δ 17.7 ((CH3)2AsO2), 19.5 ((CH3)2AsO2), 123.3 (q, 1 J CF = 272.4 Hz, CF3), 126.2 (s, C-3), 130.3 (s, C-2), 134.3 (q, 2 J CF = 32.2 Hz, C-4), 135.3 (s, C-1). 19F NMR (H2O/D2O, ppm): δ −63.1 (Figure S28).
Synthesis of NaNH4[4-F3COC6H4AsMoV 6O15(OH)3{AsO2(CH3)2}3]·10H2O (NaNH4–F3COC6H4AsMo6 )
The polyanion 4-F3COC6H4AsMo6 was prepared by following the same procedure as for C6H5AsMo6 , by replacing C6H5AsO3H2 with (4-trifluoromethoxyphenyl)arsonic acid, 4-F3COC6H4AsO3H2 (0.012 g, 0.05 mmol). The reaction mixture (pH 6.7–6.8) was stirred and heated at 80 °C for 1 h. After 2 days of cooling to room temperature, dark-red, rod-shaped crystals (Figure S4d) began to form. The total isolated yield is 0.06 g (74% based on Mo). Elemental analysis (%) calcd (found) for NaNH4–F3COC6H4AsMo6 : Na, 1.32 (1.32); Mo, 33.2 (32.2); As, 17.3 (17.3); F, 3.28 (3.36); C, 9.0 (9.4); H, 2.8 (2.4); N, 0.81 (1.21). FT-IR (2% KBr pellet, ν/cm–1): 3403 (s), 3208 (s) [ν(N–H), ν(O–H)], 3023 (w), 2929 (w) [ν(C–H)], 1630 (s) [δ(O–H)], 1495 (m), 1404 (s) [δ(C–H)], 1259 (s) [ν(As–C)], 1217 (s), 1171 (s) [ν(C–F)], 1097 (w), 969 (s) [ν(MoO)], 829 (s) [ν(As–O)], 745 (s), 657 (w), 612 (w), 494 (m), 459 (m) [δ(Mo–O(Mo))] (Figure S7e). 1H NMR (H2O/D2O, ppm): δ 1.6 (s, 9H, (CH 3)2AsO2), 2.3 (s, 9H, (CH 3)2AsO2), 7.07 (d, 2H, 3 J HH = 8 Hz, ortho-C6 H 4), 7.23 (d, 2H, 3 J HH = 8 Hz, meta-C6 H 4). 19F NMR (H2O/D2O, ppm): δ −57.7 (Figure S29). 13C{1H} NMR (H2O/D2O, ppm): δ 17.6 ((CH3)2AsO2), 19.4 ((CH3)2AsO2), 118.6 (OCF3), 121.4 (s, C-3), 129.6 (s, C-4), 131.8 (s, C-2), 152.4 (s, C-1) (Figure S30).
Synthesis of Na0.7(NH4)1.3[4-BrC6H4AsMoV 6O15(OH)3{AsO2(CH3)2}3]·8H2O (NaNH4–BrC6H4AsMo6 )
The polyanion 4-BrC6H4AsMo6 was prepared by following the same procedure as C6H5AsMo6 , by replacing C6H5AsO3H2 with (4-bromophenyl)arsonic acid, 4-BrC6H4AsO3H2 (0.014 g, 0.05 mmol). After stirring and heating the reaction mixture (pH 6.7–6.8) at 80 °C for 1 h, it was allowed to cool gradually to room temperature over 2 days, leading to the formation of dark-red, rod-shaped crystals. The total isolated yield is 0.069 g (87% based on Mo). Elemental analysis (%) calcd (found) for NaNH4–BrC6H4AsMo6: Na, 0.95 (1.25); Mo, 34.0 (34.6); As, 17.7 (18.6); Br, 4.72 (4.15); C, 8.52 (7.87); H, 2.75 (2.77); N, 1.08 (1.31). FT-IR (2% KBr pellet, ν/cm–1): 3419 (s), 3179 (s) [ν(N–H), ν(O–H)], 3008 (w), 2926 (w) [ν(C–H)], 1632 (m) [δ(O–H)], 1573 (w), 1474 (sh), 1402 (m) [δ(C–H)], 1272 (w) [ν(As–C)], 1183 (w), 1095 (w), 1063 (w) [ν(C–Br)], 1009 (w), 969 (s), 921 (w) [ν(MoO)], 834 (s) [ν(As–O)], 744 (s), 655 (w), 587 (w), 497 (m), 468 (m) [δ(Mo–O(Mo))] (Figure S7c). 1H NMR (H2O/D2O, ppm): δ 1.6 (s, 9H, (CH 3)2AsO2), 2.3 (s, 9H, (CH 3)2AsO2), 6.9 (d, 2H, 3 J HH = 9 Hz, meta-C6 H 4), 7.5 (d, 2H, 3 J HH = 9 Hz, ortho-C6 H 4). 13C{1H} NMR (H2O/D2O, ppm): δ 17.7 ((CH3)2AsO2), 19.4 ((CH3)2AsO2), 128.1 (C-4), 130.2 (C-1), 131.1 (C-3), 132.5 (C-2) (Figure S32).
High-quality crystals for single-crystal XRD were synthesized by heating Na2MoO4·2H2O (0.024 g, 0.10 mmol), N2H4·2HCl (0.011 g, 0.1 mmol), and (4-bromophenyl)arsonic acid, 4-BrC6H4AsO3H2 (0.014 g, 0.05 mmol), in 2 mL of 1 M sodium dimethylarsinate buffer (pH 7) at 80 °C for 1 h. The identity of the crystals was verified by IR spectroscopy (Figure S8).
Synthesis of Na1.3(NH4)0.7[4-N3C6H4AsMoV 6O15(OH)3{AsO2(CH3)2}3]·10H2O (NaNH4–N3C6H4AsMo6 )
The polyanion 4-N3C6H4AsMo6 was prepared by following the same procedure as C6H5AsMo6 , by replacing C6H5AsO3H2 with (4-azidophenyl)arsonic acid, 4-N3C6H4AsO3H2 (0.012 g, 0.05 mmol). Following 1 h of stirring and heating at 80 °C, the reaction mixture (pH 6.7–6.8) was left to cool at room temperature for 2 days, resulting in the formation of dark-red, rod-shaped crystals. Isolated yield: 0.072 g (91% based on Mo). Elemental analysis (%): Calcd (found) for NaNH4–N3C6H4AsMo6 : Na, 1.76 (1.94); Mo, 34.0 (34.2); As, 17.7 (18.5); C, 8.5 (7.9); H, 2.8 (2.8); N, 3.06 (2.76). FT-IR (2% KBr pellet, ν/cm–1): 3403 (s), 3185 (s) [ν(N–H), ν(O–H)], 3014 (w), 2926 (w) [ν(C–H)], 2129 (s) [ν(N3)], 1634 (s) [δ(O–H)], 1589 (sh), 1492 (sh), 1403 (s) [δ(C–H)], 1276 (s) [ν(As–C)], 1188 (w), 1133 (w), 1096 (w), 968 (m), 922 (w) [ν(MoO)], 843 (s) [ν(As–O)], 742 (m), 655 (w), 586 (m), 491 (m), 465 (m) [δ(Mo–O(Mo))] (Figure S7d). 1H NMR (H2O/D2O, ppm): δ 1.6 (s, 9H, (CH 3)2AsO2), 2.3 (s, 9H, (CH 3)2AsO2), 6.58 (d, 2H, 3 J HH = 9 Hz, ortho-C6 H 4), 6.72 (d, 2H, 3 J HH = 9 Hz, meta-C6 H 4) (Figure S34).
Synthesis of NaNH4[3,5-(HOOC)2C6H3AsMoV 6O15(OH)3{AsO2(CH3)2}3]·14H2O (NaNH4–H2O4C2C6H3AsMo6 )
The polyanion H2O4C2C6H3AsMo6 was synthesized using the same procedure for C6H5AsMo6 , substituting C6H5AsO3H2 with 3,5-bis(carboxy)phenylarsonic acid, 3,5-(HOOC)2C6H3AsO3H2 (0.015 g, 0.05 mmol). After stirring and heating at 80 °C for 1 h, the reaction mixture (pH 6.7–6.8) was cooled, centrifuged at 4000 rpm for 15 min, and filtered. The resulting red filtrate was left undisturbed in an open vial for slow crystallization. After 7 days, reddish block-shaped crystals were obtained. Isolated yield: 0.028 g (33% based on Mo). Elemental analysis (%): calcd (found) for NaNH4–H2O4C2C6H3AsMo6 : Na, 1.27 (1.52); Mo, 31.8 (30.6); As, 16.6 (16.7); C, 9.29 (9.32); H, 3.23 (3.07); N, 0.77 (1.45). FT-IR (2% KBr pellet, ν/cm–1): 3445 (s), 3229 (s) [ν(N–H), ν(O–H)], 3022 (w), 2927 (w) [ν(C–H)], 1635 (m) [δ(O–H)], 1560 (m) [υ(CO)], 1401 (m) [δ(C–H)], 1280 (w) [ν(As–C)], 1108 (w), 970 (s) [ν(MoO)], 840 (s) [ν(As–O)], 746 (m), 699 (w), 656 (w), 488 (m), 460 (m) [δ(Mo–O(Mo))] (Figure S7f). 1H NMR (H2O/D2O, ppm): δ 1.5 (s, 9H, (CH 3)2AsO2), 2.2 (s, 9H, (CH 3)2AsO2), 7.6 (s, 2H, ortho-C6 H 3), 8.3 (s, 1H, para-C6 H 3). 13C{1H} NMR (H2O/D2O, ppm): δ 17.8 ((CH3)2AsO2), 19.4 ((CH3)2AsO2), 131.8 (C-1), 133.1 (C-3), 134.0 (C-2), 135.6 (C-4), 171.0 (COOH) (Figure ).
3.
1H (left) and 13C{1H} (right) NMR spectra of NaNH4–H2O4C2C6H3AsMo6 dissolved in H2O/D2O at room temperature. The peaks corresponding to structurally and hence magnetically inequivalent carbon atoms are labeled accordingly. Color code: MoO6, violet octahedra; As, green; C, yellow; O, red; H, black.
X-ray Crystallography
Single-crystal XRD data for NaNH4–AsVMo6 were collected at 100 K using a Bruker D8 SMART APEX II CCD diffractometer with kappa geometry and a graphite monochromator (λMo Kα = 0.71073 Å), with the APEX III software package. Cell refinement and data reduction were performed using SAINT, while multiscan absorption corrections were applied via SADABS. For NaNH4–AsIIIMo6 , NaNH4–CH3AsMo6 , NaNH4–C2H5AsMo6 , NaNH4–C6H5AsMo6 , NaNH4–FC6H4AsMo6, NaNH4–F3CC6H4AsMo6 , NaNH4–F3COC6H4AsMo6 , NaNH4–BrC6H4AsMo6 , NaNH4–N3C6H4AsMo6 and NaNH4–H2O4C2C6H3AsMo6 , indexing and data collection were carried out on a Rigaku XtaLAB Synergy Dualflex HyPix single-crystal diffractometer with kappa geometry and a graphite monochromator with Mo Kα/Cu Kα radiation (λ = 0.71073/1.54184 Å) (Table S1). All measurements were conducted with crystals mounted on Hampton cryoloops with paratone-N oil at 100 K. Corrections for absorption effects were applied with CrysAlisPro 1.171.43.97a. The structures were solved by direct methods using SHELXT, and full-matrix least-squares structure refinements were performed with SHELXL-2018/3 implemented in Olex2 1.5-ac5–024. All nonhydrogen atoms were refined anisotropically. In several crystal structures, the voids contain disordered solvents. The Olex2 solvent mask routine (similar to PLATON/SQUEEZE) was used to mask out the disordered electron density. Crystallographic data for the polyanions are summarized in Table S1. The CIF files are provided free of charge by The Cambridge Crystallographic Data Centre (CCDC 2464737–2464747).
Bond Valence Sum Calculations
The bond valence sum (BVS) calculations for the molybdenum and oxygen atoms (Tables S2–S12) were conducted using a program developed by Chris Hormillosa and Sean Healy and distributed by I. D. Brown.
Antibacterial Activity: Determination of Minimal Inhibitory Concentrations (MICs) for Bacterial Cells
The MIC experiments were built upon our prior research, the procedures following our previous work and Elshamy et al. Precultures were established by inoculating single bacterial colonies into 5 mL of the appropriate liquid medium. After 24 h, the optical density (OD) at 600 nm was assessed. The resulting cell suspension was adjusted to a concentration of 2 × 106 bacterial cells per mL. To determine the MICs, 96-well plates were set up with a dilution series of NaNH4–AsVMo6 , NaNH4–CH3AsMo6 , NaNH4–C6H5AsMo6 , NaNH4–FC6H4AsMo6 , NaNH4–F3CC6H4AsMo6 , NaNH4–F3COC6H4AsMo6 , NaNH4–N3C6H4AsMo6 , NaNH4–BrC6H4AsMo6 , and NaNH4–H2O4C2C6H3AsMo6 beginning at 500 μg/mL. Stock solutions were prepared using sterile deionized water. The 96-well plates were incubated overnight at the optimal growth temperature for each organism tested. Outcomes were visually assessed, with MICs established based on the presence or absence of growth. For better visualization, resazurin was used as a fluorometric indicator to aid in determining the MICs. All MIC experiments were performed in triplicate, with three independent replicates. Agar diffusion and MIC are simple and widely known methods of determining the zone of inhibition and the lowest concentration of the samples against a defined organism, respectively.
Results and Discussion
Synthesis and Structure
A one-pot aqueous reaction of ammonium heptamolybdate, hydrazine hydrochloride, organoarsonate heterogroup, and sodium cacodylate buffer in a 1:2:1:20 molar ratio yielded a series of dimethylarsinate-functionalized arsenomolybdates: [CH3AsMoV 6O15(OH)3{AsO2(CH3)2}3]2– (CH3AsMo6 ), [C6H5AsMoV 6O15(OH)3{AsO2(CH3)2}3]2– (C6H5AsMo6 ), [FC6H4AsMoV 6O15(OH)3{AsO2(CH3)2}3]2– (4-FC6H4AsMo6 ), [F3CC6H4AsMoV 6O15(OH)3{AsO2(CH3)2}3]2– (4-F3CC6H4AsMo6 ), [F3COC6H4AsMoV 6O15(OH)3{AsO2(CH3)2}3]2– (4-F3COC6H4AsMo6 ), [BrC6H4AsMoV 6O15(OH)3{AsO2(CH3)2}3]2– (4-BrC6H4AsMo6 ), [N3C6H4AsMoV 6O15(OH)3{AsO2(CH3)2}3]2– (4-N3C6H4AsMo6 ), and [3,5-(HOOC)2C6H3AsMoV 6O15(OH)3{AsO2(CH3)2}3]2– (H2O4C2C6H3AsMo6 ), all isolated as hydrated mixed ammonium-sodium salts. These compounds were successfully synthesized within a pH range of 6.4–6.8 at room temperature, 50, or 80 °C. In each case, the formation of a dark-red solution indicated the reduction of MoVI to MoV, which was confirmed by bond valence sum (BVS) calculations (Tables S4 and S6–S12). The highest isolated yields were achieved at 80 °C, with crystallization occurring within 1 week. Substituting ammonium heptamolybdate ((NH4)6Mo7O24·4H2O) with sodium molybdate (Na2MoO4·2H2O) under identical conditions resulted in high-quality crystals, albeit at significantly lower yields. For the polyanion H2O4C2C6H3AsMo6 , BVS calculations indicated that the carboxylate moieties are monoprotonated (Table S12). Attempts to prepare the structural analogue using 4-HOOCC6H4AsO3H2 as the precursor ligand were unsuccessful. Despite numerous reactions and pH adjustments, the reported [MoVI 18MoV 12O84{AsO2(CH3)2}18]18– {Mo30 } was formed instead.
Synthesis of the three isostructural polyanions [HOAsMoV 6O15(OH)3{AsO2(CH3)2}3]2– (AsVMo6 ), [AsIIIMoV 6O15(OH)3{AsO2(CH3)2}3]3– (AsIIIMo6 ), and [C2H5AsMoV 6O15(OH)3{AsO2(CH3)2}3]2– (C2H5AsMo6 ) required precise control over the molybdate precursor, reactant ratios, temperature, and pH. The AsVMo6 polyanion was obtained under specific conditions, requiring a 1:2:1 molar ratio of ammonium heptamolybdate, hydrazine hydrochloride, and arsenate heterogroup in 10 mL of 0.5 M sodium cacodylate buffer at pH 6.6–6.8 and a reaction temperature of 80 °C. Attempts to use sodium molybdate or reduce the reaction temperature were unsuccessful. Structural analysis of AsVMo6 indicated the monoprotonation of terminal oxygen (O9) in the As–O bond (1.689 Å), with a corresponding BVS value (v ij = 1.24) (Table S2).
Conversely, AsIIIMo6 and C2H5AsMo6 were only obtained using sodium molybdate as the molybdenum source. The optimal molar ratio of sodium molybdate to As2O3 or C2H5AsO3H2 was 2:1, with reactions carried out at 80 °C within a pH range of 6.8–6.9. For these three species, prolonged heating did not improve yield, and crystallization occurred more slowly than the other members of the series.
Single-crystal XRD analysis confirmed that the molecular structures of these polyanions, [RAsMoV 6O15(OH)3{AsO2(CH3)2}3]2– (R = HO, CH3, C2H5, C6H5, 4-FC6H4, 4-F3CC6H4, 4-F3COC6H4, 4-BrC6H4, 4-N3C6H4, and 3,5-(HOOC)2C6H3) (Figure a) and [AsIIIMoV 6O15(OH)3{AsO2(CH3)2}3]3– (AsIIIMo6 ) (Figure b) closely resemble the previously reported [RPMoV 6O15(OH)3{AsO2(CH3)2}3]2– (R = H, HO, CH3, HO2CCH2, HO2CC2H4, C6H5, 4-FC6H4, and 4-F3COC6H4) and exhibit a distinct flowerpot-like architecture. The core structure consists of a cyclic hexanuclear molybdenum(V)-oxo ring, formed by three edge-sharing {MoV 2O10} fragments interconnected via hydroxo bridges (verified through BVS calculations, see Tables S2–S12). These units are capped by three dimethylarsinate ((CH3)2AsO2), also known as cacodylate ligands, which act as strongly coordinating bidentate ligands. This arrangement features alternating short Mo–Mo bonding interactions (∼2.59 Å) and longer Mo···Mo nonbonding contacts (∼3.58 Å). The reduced MoV 2 pairs adopt a highly distorted octahedral coordination geometry, with each molybdenum center coordinated by two μ2-oxo groups, Mo–O(Mo) bonds: 1.939–1.949 Å, one μ2-hydroxo group, Mo–O(Mo) bond: 2.115–2.124 Å, one terminal oxo group, MoOterm bond: 1.682–1.696 Å, one oxo-donor from the terminal dimethylarsinate, Mo–O(As) bond: 2.079–2.107 Å, and an oxo-donor from the central heterogroup, Mo–O(As) bond: 2.212–2.304 Å.
1.
(a) Combined polyhedral/ball-and-stick representation of the polyanion family [RAsMoV 6O15(OH)3{AsO2(CH3)2}3]2– (R = HO, CH3, C2H5, C6H5, 4-FC6H4, 4-F3CC6H4, 4-F3COC6H4, 4-BrC6H4, 4-N3C6H4, and 3,5-(HOOC)2C6H3), and (b) the AsIII-centered derivative [AsIIIMoV 6O15(OH)3{AsO2(CH3)2}3]3–, and (c) sodium ion-mediated dimer (formed by all polyanions in the solid state). Color code: MoO6, violet octahedra; As, green; C, yellow; O, red; H, black; Na, light blue.
The central RAsO3 heterogroups, adopting slightly distorted tetrahedral coordination, are positioned above the plane of the six molybdenum atoms and coordinate via three μ3-oxo bridges. Notably, the AsIII center in AsIIIMo6 , which adopts pyramidal geometry due to its lone pair, exhibits stronger Mo–O(As) bonding (2.212 Å) compared to the AsV center in AsVMo6 (2.289 Å). Additionally, all three peripheral dimethylarsinate ligands feature tetrahedrally coordinated As centers, with average As–O(Mo) bond lengths ranging from 1.67 to 1.80 Å. The average bond angles around As closely resemble those in uncoordinated dimethylarsinic acid (109.4°), and the As–C distances (1.90–1.94 Å) fall within the expected range, consistent with literature values. Both the peripheral ligands and the central heterogroups are grafted onto the same side of the polyanion.
Introducing a certain concentration of Na+ cations plays a crucial role in the polyanion formation, as evidenced by the solid-state structure (Figure c). A hexa-coordinated Na+ ion interacts with oxo bridges from the MoV 2 pairs (Na···O = 2.27 Å), on the opposite side of the coordinated dimethylarsinate ligands, thus facilitating Na+-mediated dimerization of the polyanions.
The precise formula units of the polyanions were determined through elemental analysis, thermogravimetric analysis (TGA) of the bulk material, bond valence sum (BVS) analysis, and single-crystal XRD analysis. The thermograms (Figures S9–S19) indicated two primary stages of weight loss. The first stage, between 25 and 130 °C, corresponds to dehydration, during which interstitial water molecules were released from the structure. The number of crystal water molecules identified by TGA and elemental analysis varied due to differences in drying times and the aging of the samples at room temperature prior to measurements. The consecutive weight loss steps between 160–480 °C were attributed to the elimination of ammonia (NH3) molecules, organic dimethylarsinate ligands, and central organic moieties, leading to complete structural decomposition.
Infrared (IR) Spectroscopy
Fourier transform infrared (FT-IR) spectra (Figures S5–S8) display bands corresponding to the asymmetric stretching (υas[O–H]) and bending (δ[O–H]) vibrations of interstitial water molecules in the regions of 3400–3000 and 1640–1620 cm–1. Furthermore, broad peaks in the 3600–3400 cm–1 range indicate the stretching vibrations of the NH4 + group. The presence of NH4 + as counter cations in the clusters is confirmed by elemental analysis. Two weak peaks in the 3030–2800 cm–1 range, along with medium-intensity bands near 1404 cm–1, are attributed to asymmetric stretching (υas[C–H]) and bending (δ[C–H]) vibrations of the methyl groups in the dimethylarsinate ligands. The characteristic bands observed between 980–850 and 600–400 cm–1 are assigned to the asymmetric stretching (υas[MoO]) and (υas[Mo–O(Mo)]) vibrations. Strong bands at 850–820 cm–1 and medium-intensity peaks at 1280–1250 cm–1 are associated with asymmetric stretching (υas[As–O]) and (υas[As–C]) vibrations. The strong band at 2120 cm–1, attributed to the asymmetric stretching of the azido group, and weak bands for asymmetric C–F stretching between 1200 and 1000 cm–1 (Figure S7) confirm the incorporation of phenylarsonate derivatives. The C–Br stretching occurs between 1093 and 1063 cm–1 (Figure S7).
Nuclear Magnetic Resonance (NMR) Studies
The solution behavior of the arsenic-containing polyanions [AsIIIMoV 6O15(OH)3{AsO2(CH3)2}3]3– and [RAsMoV 6O15(OH)3{AsO2(CH3)2}3]2– (R = HO, CH3, C2H5, C6H5, 4-FC6H4, 4-F3COC6H4, 4-F3CC6H4, 4-BrC6H4, 4-N3C6H4, and 3,5-(HOOC)2C6H3) was examined using multinuclear (1H, 19F, and 13C{1H}) NMR spectroscopy following the redissolution of the solid salts in a H2O/D2O mixture. These polyanions demonstrated greater solubility in water than their phosphorus-containing counterparts. Most polyanions dissolved readily at room temperature, except for NaNH4–CH3AsMo6 and NaNH4–C2H5AsMo6 , which required heating to 40 °C.
The reference compounds, including dimethylarsinic acid, (CH3)2AsO2H (cacodylic acid, H-Cac, pH 4.10), and sodium dimethylarsinate, (CH3)2AsO2Na (sodium cacodylate, Na-Cac, pH 6.0), displayed distinct NMR signals at δ = 1.8 and 1.6 ppm (1H) and δ = 17.0 and 16.7 ppm (13C{1H}) in H2O/D2O, corresponding to the two equivalent methyl groups attached to the arsenic center. For the bioactive polyanions NaNH4–C6H5AsMo6 , NaNH4–F3COC6H4AsMo6 , and NaNH4–BrC6H4AsMo6 , the solutions were carefully adjusted to pH 7 using a 1 M NaOH solution prior to the measurements.
The 1H NMR spectra of polyanions AsIIIMo6 and AsVMo6 exhibited distinct singlets at δ = 2.0 and 1.6 ppm (intensity ratio 1:1) for the former and δ = 2.2 and 1.9 ppm (intensity ratio 1:1) for the latter (Figure a). The 13C{1H} NMR spectra showed sharp resonances at δ = 19.4 and 17.9 ppm for AsIIIMo6 and closely spaced peaks at δ = 18.9 and 18.7 ppm for AsVMo6 (Figure b), corresponding to the nonequivalent methyl groups of the coordinated dimethylarsinate moiety, consistent with the solid-state structure. Although all cacodylates in the polyanions are structurally equivalent, their two methyl groups are not. A careful examination of the polyanion structure reveals that one methyl group points toward the heterogroup at the center, while the other extends outward, resulting in structural and thus magnetic inequivalence. The minor peaks at 1.62 ppm (1H) and 17.0 ppm (13C{1H}) in the AsIIIMo6 spectra were attributed to decomposed free cacodylate.
For the methylarsonate analogue CH3AsMo6 , the peaks at δ = 2.4 and 2.0 ppm (1H) (Figure S20a) and δ = 19.7 and 18.0 ppm (13C{1H}) (Figure S20b) correspond to the nonequivalent methyl groups of the coordinated cacodylate ligands, as expected. The signals at δ = 0.96 ppm (1H) and δ = 18.9 ppm (13C{1H}) are attributed to the central methyl arsonate ligand. Additionally, minor decomposition of the bound cacodylate moieties is evident from peaks at δ = 1.7 ppm (1H) and δ = 17.1 ppm (13C{1H}). The solution stability of AsVMo6 and CH3AsMo6 was monitored via 13C{1H} NMR over 1 week. No spectral changes were observed for AsVMo6 , indicating complete stability, whereas CH3AsMo6 exhibited minor cacodylate decomposition over time (Figure S21). Overall, these findings confirm that the cacodylate groups remain strongly bound to the polyanion, consistent with a previous report.
For the ethylarsonate analogue C2H5AsMo6 , the 1H NMR spectrum displayed singlets at δ = 2.3 and 1.9 ppm (methyl groups of cacodylates), a quartet at δ = 1.2 ppm (−CH2), and a triplet at δ = 0.6 ppm (−CH3, 3 J = 8 Hz) (Figure S22). Due to the compound’s low solubility, even after heating to 40 °C, obtaining a reliable 13C{1H} NMR spectrum was challenging.
The 1H NMR spectrum of C6H5AsMo6 exhibited resonances at δ = 2.3 and 1.6 ppm (methyl groups of the coordinated cacodylate ligands). In the aromatic region, a doublet at δ = 7.07 ppm (3J = 8 Hz) and triplets at δ = 7.37 ppm (3 J = 8 Hz) and 7.46 ppm (3 J = 8 Hz) were assigned to the ortho, meta, and para protons of the phenylarsonate framework, respectively (Figure S23a). The 13C{1H} NMR spectrum showed corresponding signals at δ = 19.5 and 17.8 ppm (methyl groups of cacodylates) along with peaks at δ = 129.40 (meta), 129.72 (ortho), 131.18 (para), and 133.64 ppm (ipso) (Figure S23b). Additionally, minor peaks at δ = 1.8 ppm (1H) and 17.0 ppm (13C{1H}) were attributed to slight cacodylate decomposition. A one-week analysis of the 1H and 13C{1H} NMR spectra confirmed the polyanion’s stability, apart from minor decomposition of the cacodylate ligands (Figure S24).
In the 19F NMR spectra of the fluorinated polyanions 4-FC6H4AsMo6 , 4-F3CC6H4AsMo6 , and 4-F3COC6H4AsMo6 , singlet resonances were observed at −104.5 ppm (Figure S26a), −63.1 ppm (Figure S28a), and −57.7 ppm (Figure S29a), respectively. In the 1H NMR spectrum of 4-FC6H4AsMo6 , unresolved multiplets were observed around 7.06 ppm. In contrast, the spectrum of 4-F3CC6H4AsMo6 showed well-resolved doublets corresponding to the ortho and meta aromatic protons at 7.18 and 7.67 ppm, respectively. The 13C{1H} NMR spectra of 4-FC6H4AsMo6 and 4-F3CC6H4AsMo6 displayed signals at δ = 19.7 and 17.9 ppm (Figure S26b) and δ = 19.5 and 17.7 ppm (Figure S28b), respectively, assigned to the methyl carbons of the coordinated cacodylate moieties. For 4-FC6H4AsMo6 , carbon–fluorine coupling resulted in characteristic doublets at δ = 165.7 ppm (para, 1 J C–F = 261.35 Hz), 132.5 ppm (ortho, 3 J C–F = 8.44 Hz), and 116.9 ppm (meta, 2 J C–F = 22.14 Hz), while the ipso carbon appeared as a singlet at δ = 127.2 ppm. In the trifluoromethyl analogue 4-F3CC6H4AsMo6 , quartets at δ = 123.3 ppm (−CF3, 1 J C–F = 272.4 Hz) and 134.3 ppm (para, 2 J C–F = 32.2 Hz) were observed due to carbon–fluorine coupling from the trifluoromethyl group. The peaks at δ = 126.2, 130.3, and 135.3 ppm were assigned to the meta, ortho, and ipso carbons, respectively. In both cases, the minor peak at δ = 17.0 ppm was attributed to free cacodylate, and in 4-F3CC6H4AsMo6 , an additional unassigned signal was detected at δ = 20.0 ppm.
The 1H NMR spectrum of the polyanion 4-F3COC6H4AsMo6 displayed characteristic resonances at δ = 1.6 and 2.3 ppm (methyl groups of cacodylates) along with peaks in the aromatic region, doublets at δ = 7.07 ppm (3 J = 8 Hz) and 7.23 ppm (3 J = 8 Hz) corresponding to the ortho and meta protons of the phenyl ring, respectively (Figure S29b). The 13C{1H} NMR spectrum provided peaks at δ = 152.4 ppm (ipso), 131.8 ppm (ortho), 129.6 ppm (para), 121.4 ppm, (meta) and 118.6 ppm (−OCF3) in the aromatic region. Long-term monitoring of the 1H and 19F NMR spectra over 1 week confirmed the polyanion’s stability, aside from minor cacodylate decomposition (Figure S31).
For the polyanion 4-BrC6H4AsMo6 , the 1H NMR spectrum gave doublets at δ = 6.9 ppm (meta, 3 J = 9 Hz) and 7.5 ppm (ortho, 3 J = 9 Hz) in the aromatic region (Figure S32a). The 13C{1H} NMR spectrum revealed resonances at δ = 128.1 ppm (para), 130.2 ppm (ipso), 131.1 ppm (meta), and 132.5 ppm (ortho), corresponding to the aromatic carbons (Figure S32b). Distinct peaks at δ = 2.3 and 1.6 ppm (1H) and δ = 19.4 and 17.7 ppm (13C{1H}) were assigned to the inequivalent methyl groups of the coordinated cacodylate moieties. Additionally, peaks at δ = 1.7 ppm (1H) and δ = 16.9 ppm (13C{1H}) were attributed to free cacodylate species. Time-dependent 1H NMR spectra suggested decomposition of the cacodylate moiety without significant structural changes (Figure S33).
The polyanion 4-N3C6H4AsMo6 exhibited the expected 1H NMR signals for the cacodylate methyl protons at δ = 2.3 and 1.6 ppm. Aromatic phenyl protons appeared as doublets at δ = 6.58 ppm (ortho, 3 J = 9 Hz) and 6.72 ppm (meta, 3 J = 9 Hz) (Figure S34). However, additional unassigned peaks at δ = 6.97, 7.59, and 7.64 ppm persisted in time-dependent studies, suggesting partial decomposition of the centrally bound ligand and instability of the polyanion upon dissolution.
For the polyanion H2O4C2C6H3AsMo6 , 1H NMR showed peaks at δ = 7.6 and 8.3 ppm, corresponding to the ortho and para aromatic protons, respectively, and signals at δ = 1.5 and 2.2 ppm for the methyl protons of the coordinated cacodylate. In the 13C{1H} NMR spectrum, signals at δ = 171.0, 135.6, 133.1, 134.0, and 131.8 ppm were assigned to the carboxylate group and the para, meta, ortho, and ipso carbons of the phenyl ring, respectively. Peaks at 19.4 and 17.8 ppm correspond to the bound cacodylates (Figure ). As in previous cases, signals at δ = 1.8 ppm (1H) and 16.9 ppm (13C{1H}) were attributed to free cacodylate species.
UV–Vis Spectroscopy
The stability of the bioactive polyanions C6H5AsMo6 , 4-F3COC6H4AsMo6 , and 4-BrC6H4AsMo6 was further evaluated by UV–vis spectroscopy (Figures S35). Three absorption bands were observed at 200, 230–254, and 320 nm. The 200 nm band corresponds to the pπ–dπ charge transfer transition of the Ot → Mo, while the 230–254 nm band arises from Ob,c → Mo charge transfer and π–π* transitions within the aromatic ring. The intense 320 nm absorption signifies ligand-to-metal charge transfer (LMCT), involving electron transfer from the filled π-orbitals of surrounding oxygens to the vacant d orbitals of Mo5+ centers. The unchanged position and intensity of these bands suggest that no significant structural transformations occurred.
ESI Mass Spectrometry
ESI mass spectra of the polyanions were acquired from aqueous solution in both positive and negative ion mode. In positive ion mode, complex spectra with multiple Mo x species could be observed. In most cases, the intact polyanion corresponded to the dominant signal. Four such examples are shown in the Supporting Information (Figures S36–S39).
In negative ion mode, all compounds analyzed showed high-quality ESI-MS spectra with a systematic pattern. All compounds showed two strong cluster of ions, a first between m/z 680–750 and a second between m/z 1380–1540. For a detailed discussion we selected two representative examples C6H5AsMo6 and 4-FC6H4AsMo6 . All mass spectrometry data are summarized in Table S13.
The polyanion C6H5AsMo6 showed a first cluster of signals at m/z 714.55 and a second cluster at m/z 1452.09 (Figure ). The first cluster at m/z 714.55 was assigned to a doubly charged negative ion with an elemental composition of [Mo6As4C12H26O24]2–. The observed isotope pattern is in full agreement with the structure as demonstrated by comparison of the experimental spectrum to a simulation of the spectrum. The second cluster at m/z 1452.09 was assigned to originate from two individual species in the gas phase. First, a monomeric singly charged species with an elemental composition of [NaMo6As4C12H26O24]− with a mass difference of 1 m/z between isotope peaks. Second, in between these signals a second species with isotope differences of 0.5 m/z was observed, which was assigned to a dimeric species with an elemental composition of [NaMo6As4C12H26O24]2 2–.
4.
Negative mode ESI mass spectra of compound C6H5AsMo6 . (A) Full-scan full-range view with two main signal clusters, (B) expanded region around m/z 714 with experimental spectra in the upper panel and a simulated isotope pattern in the bottom panel, and (C) expanded region around m/z 1452 with experimental spectra in the upper panel (please note signals of dimeric species at a 0.5 m/z mass difference at lower intensity in between main signals) and simulated isotope pattern in the bottom panel.
Again, simulated spectra are in full agreement with experimental spectra (see Figure for 4-FC6H4AsMo6 as an example). As demonstrated from single-crystal X-ray structural data, the compound as well dimerizes in the gas phase with a central Na ion, reminiscent of a 15-crown-5 crown ether. From the relative ion intensities of the two monomeric species and the single dimeric species, a ratio of monomer to dimer of 3.1 was determined. When comparing monomer to dimer ratios, it appears that electron-withdrawing substituents on the para-position of the aromatic moiety attached to As favor and stabilize the dimeric species in the gas phase.
5.
Experimental (upper panel) and simulated (bottom panel) mass spectra of 4-FC6H4AsMo6 at m/z 723 and 1469. Panel A shows simulation of doubly charged monomeric species [Mo6As4FC12H25O24]2–; panel B shows singly charged monomeric species [Mo6As4FC12H25O24Na]−, and panel C shows simulation of doubly charged dimeric species [NaMo6As4FC12H25O24]2 2–.
The ESI spectra are reminiscent of related phosphorus-containing analogues reported earlier. In three samples containing a 4-trifluoromethoxy, 4-bromo, or azido substituent on an aromatic moiety, an additional cluster of signals could be observed with an additional mass increment of 125 m/z (Figures S40–S42). We tentatively assign this mass difference to added water molecules.
Tandem Mass Spectrometry
Due to the stability of the compounds in the solution and in the gas-phase, tandem MS experiments could be carried out. The C6H5AsMo6 ions were isolated in the quadrupole with an isolation width of 20 m/z and fragmented at a collision energy of 50 eV. Fragment spectra of monomeric doubly charged species at m/z 714 (Figure ) and singly charged species at m/z 1452 as precursor ions were almost identical. Key fragment ion clusters could be observed centered at m/z 719.4, 575.2, 431.6. The same fragment ions could be observed for another compound subjected to tandem MS analysis (see Figure S43).
By comparison of experimental and simulated mass spectra, the fragment ions were assigned as [Mo5O15H4]− at m/z 719, [C6H5AsMo6O17(OH){AsO2(CH3)2}]2– at m/z 575, and [C6H5AsMo6O17(OH){AsO2(CH3)2}2]3– at m/z 431. Consequently, the polyanions loose in the gas phase up to two dimethylarsinate ligands and in addition the central arsenic moiety to yield stable Mo x O3x species (Figure ).
6.
(A) Tandem MS spectra in negative mode of C6H5AsMo6 with the precursor ion at m/z 714. Panel B shows experimental and simulated spectra of the fragment ion centered around m/z 719, panel C of the experimental and simulated fragment ion at m/z 575, and panel D experimental and simulated spectra at m/z 431.
Biological Activity Determination of Minimal Inhibitory Concentrations (MIC)
The antimicrobial efficacy of organoarsonate-functionalized polyoxomolybdates was assessed against the Gram-negative bacteria Escherichia coli (DSM 6897, grown in LB Medium), Vibrio parahaemolyticus (grown in LB Medium) and Salmonella enterica (DSM 19587, grown in LB Medium) as well as the Gram-positive bacteria Bacillus subtilis (DSM 1088, grown in TSY Medium) and Listeria monocytogenes (DSM 15675, grown in LB Medium).
All tested POMs exhibited MIC values exceeding 500 μg/mL against all Gram-negative bacteria. Only the POM 4-BrC6H4AsMo6 gave weak activity against V. parahaemolyticus (250 μg/mL) and S. enterica (500 μg/mL), indicating an overall negligible antibacterial activity (Table ). This suggests that the outer membrane of Gram-negative bacteria is a strong permeability barrier, limiting the intracellular accumulation of these large, charged molecules. Similar findings have been reported for other polyoxometalates, which generally demonstrate low efficacy against Gram-negative bacteria due to their structural properties.
1. Minimum Inhibitory Concentration (MIC) Values (μg/mL) of the Polyanions Reported Here against Three Different Gram-Negative and Two Gram-Positive Bacteria.
| microorganism | C 6 H 5 AsMo 6 | 4-F 3 COC 6 H 4 AsMo 6 | 4-BrC 6 H 4 AsMo 6 | other POMs | |
|---|---|---|---|---|---|
| Escherichia coli | Gram-negative | >500 | >500 | >500 | >500 |
| Vibrio parahaemolyticus | Gram-negative | >500 | >500 | 250 | >500 |
| Salmonella enterica | Gram-negative | >500 | >500 | 500 | >500 |
| Bacillus subtilis | Gram-positive | 250 | 62.5–125 | 125 | >500 |
| Listeria monocytogenes | Gram-positive | >500 | 303 | 40 | >500 |
Other POMs are AsVMo6 , CH3AsMo6 , 4-FC6H4AsMo6 , 4-F3CC6H4AsMo6 , 4-N3C6H4AsMo6 , and H2O4C2C6H3AsMo6 .
However, certain POMs with aromatic or halogenated phenyl groups (e.g., NaNH4–C6H5AsMo6 , NaNH4–F3COC6H4AsMo6 , and NaNH4–BrC6H4AsMo6 ) demonstrate moderate activity against the Gram-positive bacteria B. subtilis and L. monocytogenes, with MICs ranging from 62.5 to 250 μg/mL and 40–303 μg/mL, respectively. The agar diffusion plates confirm the activity of 4-BrC6H4AsMo6 as the best sample with the highest clear zone of inhibition against the pathogen Listeria monocytogenes (Figure S44). This activity may be attributed to the lack of an outer membrane compared to Gram-negative bacteria, allowing for easier cell wall penetration and showing a clear distinction in susceptibility between these bacterial types. MIC values of the control gentamycin lie in the general ranges for all bacterial strains.
Previous studies have demonstrated that halogenation can enhance bioactivity by altering compound–membrane interactions and improving uptake. All active compounds have a phenyl ring, which supports the findings that the phenyl ring serves as a structural backbone and the antimicrobial activity depends on the substituents. Among the tested compounds, 4-BrC6H4AsMo6 exhibited the highest antibacterial activity, likely due to the effect of bromine substitution on the polyanion structure (Figure S44). Control studies using the reference ligands sodium cacodylate and BrC6H4AsO3H2 against Listeria monocytogenes showed MIC values of >1000 and 62.5 μg/mL, respectively. This indicates that while the BrC6H4AsO3H2 ligand alone exhibits moderate activity, the corresponding polyanion 4-BrC6H4AsMo6 displays enhanced efficacy with an MIC of 40 μg/mL. Hence, this could lead to medicinal relevance in combating bacterial diseases for both Gram-positive and Gram-negative pathogenic microbes, although further structure–activity relationship (SAR) studies are necessary to elucidate the underlying mechanisms.
Conclusions
In summary, we have conducted a comprehensive investigation into the synthesis and characterization of a novel family of water-soluble, stable, and organically-functionalized, reduced polyoxomolybdates. Eleven dimethylarsinate-functionalized arsenomolybdates(V), [RAsMoV 6O15(OH)3{AsO2(CH3)2}3]2– (R = HO, CH3, C2H5, C6H5, 3,5-(HOOC)2C6H3, 4-FC6H4, 4-F3CC6H4, 4-F3COC6H4, 4-BrC6H4, and 4-N3C6H4) and [AsIIIMoV 6O15(OH)3{AsO2(CH3)2}3]3–, were successfully isolated via a straightforward one-pot aqueous synthesis under ambient, open-beaker conditions. Fine-tuning of reagent stoichiometry, ionic strength, and most critically, pH was essential to achieve selective formation of the target species. The incorporation of structurally diverse organoarsonate groups, including fluorinated, brominated, and carboxylated substituents, within a robust hexamolybdate(V) core provided a versatile platform to examine solubility and solution stability near physiological pH. Detailed multinuclear NMR (1H, 19F, and 13C) spectroscopy confirmed their structural integrity in solution, while ESI-MS revealed the coexistence of both monomeric and dimeric species. Moreover, tandem MS (CID) enabled stepwise fragmentation studies of the peripherally bound dimethylarsinate ligands, offering insights into the gas-phase behavior of these complex assemblies. Given the tunable organic functionality, these polyanions present exciting opportunities for biomolecular interaction studies. Preliminary biological assays revealed that the three derivatives C6H5AsMo6 , 4-F3COC6H4AsMo6 , and 4-BrC6H4AsMo6 exhibit moderate antibacterial activity, suggesting some potential as functional POM-based antimicrobial agents.
Supplementary Material
Acknowledgments
U.K. thanks the German Research Council (DFG KO-2288/31-1 and KO-2288/33-1) and Constructor University (formerly Jacobs University) for research support. The polyanion structures in Figures 1−4 were generated with Diamond, version 3.2 (Crystal Impact GbR).
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.inorgchem.5c02852.
Single-crystal XRD data, bond valence sum calculations, FT-IR spectra, thermograms, multinuclear NMR spectra (1H, 19F, and 13C), ESI-MS data and spectra, tandem MS spectrum, UV–vis spectra, agar diffusion test, and MIC plate images (PDF)
U.K. supervised the project and provided overall guidance on the research direction. V.S. synthesized the compounds, conducted material characterization, and drafted the manuscript. A.P. synthesized and initially characterized the halogenated and azido ligands and their polyanions and contributed to XRD measurements and data analysis. A.S. synthesized and characterized the dicarboxylate ligand and its corresponding polyanion. B.S.B. assisted with the XRD measurements and data interpretation. A.I. and J.Z. performed the antibacterial assays and coauthored the corresponding section, with M.S.U. providing final edits. J.H. conducted the mass spectrometry experiments, while N.K. analyzed the data and authored the mass spectrometry section. L.K. and C.S. provided the ethyl arsonate ligand used in the study. All authors reviewed and contributed to the final version of the manuscript.
The authors declare no competing financial interest.
References
- Pope, M. T. Heteropoly and Isopoly Oxometalates; Springer: Berlin, 1983. [Google Scholar]
- a Li N., Liu J., Dong B.-X, Lan Y.-Q.. Polyoxometalate-Based Compounds for Photo/electrocatalytic Applications. Angew. Chem., Int. Ed. 2020;59:20779–20793. doi: 10.1002/anie.202008054. [DOI] [PubMed] [Google Scholar]; b Rhule J. T., Hill C. L., Judd D. A., Schinazi R. F.. Polyoxometalates in Medicine. Chem. Rev. 1998;98:327–358. doi: 10.1021/cr960396q. [DOI] [PubMed] [Google Scholar]; c Bijelic A., Rompel A.. The use of polyoxometalates in protein crystallography – An attempt to widen a well-known bottleneck. Coord. Chem. Rev. 2015;299:22–38. doi: 10.1016/j.ccr.2015.03.018. [DOI] [PMC free article] [PubMed] [Google Scholar]; d Lentink S., Salazar Marcano D. E., Moussawi M. A., Parac-Vogt T. N.. Exploiting Interactions between Polyoxometalates and Proteins for Applications in (Bio)Chemistry and Medicine. Angew. Chem., Int. Ed. 2023;62:e202303817. doi: 10.1002/anie.202303817. [DOI] [PubMed] [Google Scholar]; e Kortz U., Müller A., van Slageren J., Schnack J., Dalal N. S., Dressel M.. Polyoxometalates: Fascinating structures, unique magnetic properties. Coord. Chem. Rev. 2009;253:2315–2327. doi: 10.1016/j.ccr.2009.01.014. [DOI] [Google Scholar]; f Clemente-Juan J. M., Coronado E., Gaita-Ariño A.. Magnetic polyoxometalates: from molecular magnetism to molecular spintronics and quantum computing. Chem. Soc. Rev. 2012;41:7464–7478. doi: 10.1039/c2cs35205b. [DOI] [PubMed] [Google Scholar]; g Zhang Y., Liu J., Li S.-L., Su Z.-M., Lan Y.-Q.. Polyoxometalate-based materials for sustainable and clean energy conversion and storage. EnergyChem. 2019;1:100021. doi: 10.1016/j.enchem.2019.100021. [DOI] [Google Scholar]; h Zhang Y., Li Y., Guo H., Guo Y., Song R.. Recent advances in polyoxometalate-based materials and their derivatives for electrocatalysis and energy storage. Mater. Chem. Front. 2024;8:732–768. doi: 10.1039/D3QM01000G. [DOI] [Google Scholar]
- a Pope, M. T. ; Müller, A. . Polyoxometalates: From Platonic Solids to Anti-Retroviral Activity; Kluwer Academic Publishers: Dordrecht, The Netherlands, 1994. [Google Scholar]; b Gouzerh P., Proust A.. Main-Group Element, Organic, and Organometallic Derivatives of Polyoxometalates. Chem. Rev. 1998;98:77–111. doi: 10.1021/cr960393d. [DOI] [PubMed] [Google Scholar]; c Dolbecq A., Dumas E., Mayer C. R., Mialane P.. Hybrid Organic–Inorganic Polyoxometalate Compounds: From Structural Diversity to Applications. Chem. Rev. 2010;110:6009–6048. doi: 10.1021/cr1000578. [DOI] [PubMed] [Google Scholar]
- Siby V., Pal A., Bassil B. S., Bhattacharya S., Sundar A., Oberstein J., Kim D., Gupta R., Kuanysh A., Hölscher J., Schmidt D., Kuhnert N., Kortz U.. Organophosphonate- and dimethylarsinate-functionalized hexamolybdates(V) and their solution and gas phase properties. Inorg. Chem. Front. 2025;12:3166–3178. doi: 10.1039/D4QI03215B. [DOI] [Google Scholar]
- a Haushalter R. C., Lai F. W.. [Et4N]6[Na14Mo24P17O97(OH)31]·xH2O: A Hollow Cluster Filled with 12 Na⊕ Ions and a H3PO4 Molecule. Angew. Chem., Int. Ed. 1989;28:743–746. doi: 10.1002/anie.198907431. [DOI] [Google Scholar]; b Haushalter R. C., Lai F. W.. Synthesis of a New One-Dimensional Sodium Molybdenum Phosphate Polymer: Structure of [(H3O)2NaMo6P4O24(OH)7]2– . Inorg. Chem. 1989;28:2904–2905. doi: 10.1021/ic00314a004. [DOI] [Google Scholar]; c Haushalter R. C., Mundi L. A.. Reduced Molybdenum Phosphates: Octahedral-Tetrahedral Framework Solids with Tunnels, Cages, and Micropores. Chem. Mater. 1992;4:31–48. doi: 10.1021/cm00019a012. [DOI] [Google Scholar]
- a Cao G., Haushalter R. C., Strohmaier K. G.. A Novel Polyoxo Molybdenum(V) Organophosphonate Anion Having a Sandwich Structure: Synthesis and Crystal Structure of [N(C2H5)4]2Na3(H3O)4{Na[Mo6O15(O3PC6H5)(HO3PC6H5)3]2}·14H2O. Inorg. Chem. 1993;32:127–128. doi: 10.1021/ic00054a003. [DOI] [Google Scholar]; b Khan M. I., Chen Q., Zubieta J.. Hydrothermal synthesis and crystal structure of (NH4)5Na4{Na[Mo6O15(HO3PC6H5)3(O3PC6H5)]2}·6H2O. Inorg. Chim. Acta. 1993;206:131–133. [Google Scholar]; c Khan M. I., Chen Q., Zubieta J.. Oxomolybdenum(V) polyanion clusters. Hydrothermal syntheses and structures of (NH4)5Na4{Na[Mo6O12(OH)3(O3PC6H5)4]2}·6H2O and (C6H5CH2NMe3)4K4{K2[Mo6O12(OH)3(O3PC6H5)4]2}·10H2O and their relationship to the binuclear (Et4N)[Mo2O4Cl3(H2O)3]·5H2O. Inorg. Chim. Acta. 1995;235:135–145. doi: 10.1016/0020-1693(95)90054-A. [DOI] [Google Scholar]; d Chang Y. D., Zubieta J.. Investigations into the syntheses and structures of clusters of the Mo-O-REO3 2– systems (E = P and As) Inorg. Chim. Acta. 1996;245:177–198. doi: 10.1016/0020-1693(95)04810-3. [DOI] [Google Scholar]
- Cadot E., Dolbecq A., Salignac B., Sécheresse F.. Self-Condensation of [MoV 2O2S2]2+ with Phosphate or Arsenate Ions by Acid-Base Processes in Aqueous Solution: Syntheses, Crystal Structures, and Reactivity of [(HXO4)4Mo6S6O6(OH)3]5–, X = P. As. Chem.Eur. J. 1999;5:2396–2403. doi: 10.1002/(SICI)1521-3765(19990802)5:8<2396::AID-CHEM2396>3.0.CO;2-C. [DOI] [Google Scholar]
- a Dolbecq A., Lisnard L., Mialane P., Marrot J., Bénard M., Rohmer M.-M., Sécheresse F.. Synthesis and Characterization of Octa- and Hexanuclear Polyoxomolybdate Wheels: Role of the Inorganic Template and of the Counterion. Inorg. Chem. 2006;45:5898–5910. doi: 10.1021/ic060410+. [DOI] [PubMed] [Google Scholar]; b du Peloux C., Dolbecq A., Mialane P., Marrot J., Sécheresse F.. Template synthesis of {(MoV 2O4)(O3PCH2PO3)}n clusters (n = 3, 4, 10): solid state and solution studies. Dalton Trans. 2004:1259–1263. doi: 10.1039/b401250j. [DOI] [PubMed] [Google Scholar]; c Dumas E., Sassoye C., Smith K. D., Sevov S. C.. Synthesis and Characterization of [Mo7O16(O3PCH2PO3)3]8–: A Mixed-Valent Polyoxomolybdenum Diphosphonate Anion with Octahedrally and Tetrahedrally Coordinated Molybdenum. Inorg. Chem. 2002;41:4029–4032. doi: 10.1021/ic0202209. [DOI] [PubMed] [Google Scholar]
- Emsley, J. Nature’s Building Blocks: An A-Z Guide to the Elements; Oxford University Press: Oxford, U.K., 2011. [Google Scholar]
- Imoto H., Naka K.. The Dawn of Functional Organoarsenic Chemistry. Chem.Eur. J. 2019;25:1883–1894. doi: 10.1002/chem.201804114. [DOI] [PubMed] [Google Scholar]
- a Barkigia K. M., Rajković L. M., Pope M. T., Quicksall C. O.. New type of heteropoly anion. Tetramolybdo complexes of dialkyl- and diarylarsinates. J. Am. Chem. Soc. 1975;97:4146–4147. doi: 10.1021/ja00847a056. [DOI] [Google Scholar]; b Barkigia K. M., Rajković-Blazer L. M., Pope M. T., Prince E., Quicksall C. O.. Molybdoarsinate Heteropoly Complexes. Structure of the Hydrogen Tetramolybdodimethylarsinate(2-) Anion by X-Ray and Neutron Diffraction. Inorg. Chem. 1980;19:2531–2537. doi: 10.1021/ic50211a009. [DOI] [Google Scholar]
- Rosenheim A., Bilecki R.. Über Molybdänsäure-alkylarsinate. (Zur Kenntnis der Iso- Und Heteropolysalze. VIII. Mitteilung.) Ber. Dtsch. Chem. Ges. 1913;46:539–557. doi: 10.1002/cber.19130460173. [DOI] [Google Scholar]
- Kwak W., Rajković L. M., Stalick J. K., Pope M. T., Quicksall C. O.. Synthesis and Structure of Hexamolybdobis(organoarsonates) Inorg. Chem. 1976;15:2778–2783. doi: 10.1021/ic50165a042. [DOI] [Google Scholar]
- a Matsumoto K. Y.. The Crystal Structure of Guanidinium Hexamolybdobis(phenylarsonate) Tetrahydrate, (CN3H6)4[(C6H5As)2Mo6O25H2]·4H2O. Bull. Chem. Soc. Jpn. 1978;51:492–498. doi: 10.1246/bcsj.51.492. [DOI] [Google Scholar]; b Liu B. Y., Ku Y. T., Wang M., Zheng P. J.. Synthesis and Characterization of a New Type of Heteropolyanion: Pentamolybdobis(n-propylarsonate), Having Two Types of Crystals under the Same pH Conditions in the Same Solution. Inorg. Chem. 1988;27:3868–3871. doi: 10.1021/ic00294a040. [DOI] [Google Scholar]
- a Manna P., Bhattacharya S., Kortz U.. Arylarsonate- and Phosphonate-Capped Polyoxomolybdates, [(RC6H4As)2Mo6O24]n– and [(R′C6H4P)2Mo5O21]n– . Inorg. Chem. 2021;60:7161–7167. doi: 10.1021/acs.inorgchem.1c00245. [DOI] [PubMed] [Google Scholar]; b Pal A., Bhattacharya S., Ma X., Kiran A. B., Silvestru C., Kortz U.. Fluorinated Arylarsonate-Containing Polyoxomolybdates: pH-Dependent Formation of Mo6 vs Mo12 Species and Their Solution Properties. Inorg. Chem. 2024;63:18838–18846. doi: 10.1021/acs.inorgchem.4c02951. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kortz U., Savelieff M. G., Ghali F. Y. A., Khalil L. M., Maalouf S. A., Sinno D. I.. Heteropolymolybdates of AsIII, SbIII, BiIII, SeIV, and TeIV Functionalized by Amino Acids. Angew. Chem., Int. Ed. 2002;41:4070–4073. doi: 10.1002/1521-3773(20021104)41:21<4070::AID-ANIE4070>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
- a Bijelic A., Aureliano M., Rompel A.. The antibacterial activity of polyoxometalates: structures, antibiotic effects and future perspectives. Chem. Commun. 2018;54:1153–1169. doi: 10.1039/C7CC07549A. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Aureliano M.. The Future Is Bright for Polyoxometalates. BioChem. 2022;2:8–26. doi: 10.3390/biochem2010002. [DOI] [Google Scholar]; c Mousavi S. M., Hashemi S. A., Mazraedoost S., Chiang W.-H., Yousefi K., Arjmand O., Ghahramani Y., Gholami A., Omidifar N., Pynadathu Rumjit N., Salari M., Sadrmousavi-Dizaj A.. Anticancer, antimicrobial and biomedical features of polyoxometalate as advanced materials: A review study. Inorg. Chem. Commun. 2022;146:110074. doi: 10.1016/j.inoche.2022.110074. [DOI] [Google Scholar]; d Čolović M. B., Lacković M., Lalatović J., Mougharbel A. S., Kortz U., Krstić D. Z.. Polyoxometalates in biomedicine: Update and overview. Curr. Med. Chem. 2020;27:362–379. doi: 10.2174/0929867326666190827153532. [DOI] [PubMed] [Google Scholar]
- a Cao Z., Yang W., Min X., Liu J., Cao X.. Recent advances in synthesis and anti-tumor effect of organism-modified polyoxometalates inorganic organic hybrids. Inorg. Chem. Commun. 2021;134:108904. doi: 10.1016/j.inoche.2021.108904. [DOI] [Google Scholar]; b Salazar Marcano D. E., Parac-Vogt T. N.. Hybrid functional materials merging polyoxometalates and biomolecules: From synthesis to applications. Coord. Chem. Rev. 2024;518:216086. doi: 10.1016/j.ccr.2024.216086. [DOI] [Google Scholar]; c Gumerova N. I., Rompel A.. Synthesis, structures and applications of electron-rich polyoxometalates. Nat. Rev. Chem. 2018;2:0112 [Google Scholar]
- Fongang H., Mbaveng A. T., Kuete V.. Global burden of bacterial infections and drug resistance. Adv. Bot. Res. 2023;106:1–20. [Google Scholar]
- a Hernandes M. Z., Cavalcanti S. M. T., Moreira D. R. M., de Azevedo Junior W. F., Leite A. C. L.. Halogen Atoms in the Modern Medicinal Chemistry: Hints for the Drug Design. Curr. Drug. Targets. 2010;11:303–314. doi: 10.2174/138945010790711996. [DOI] [PubMed] [Google Scholar]; b Inoue M., Sumii Y., Shibata N.. Contribution of Organofluorine Compounds to Pharmaceuticals. ACS Omega. 2020;5:10633–10640. doi: 10.1021/acsomega.0c00830. [DOI] [PMC free article] [PubMed] [Google Scholar]; c Hagmann W. K.. The Many Roles for Fluorine in Medicinal Chemistry. J. Med. Chem. 2008;51:4359–4369. doi: 10.1021/jm800219f. [DOI] [PubMed] [Google Scholar]; d Wilcken R., Zimmermann M. O., Lange A., Joerger A. C., Boeckler F. M.. Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology. J. Med. Chem. 2013;56:1363–1388. doi: 10.1021/jm3012068. [DOI] [PubMed] [Google Scholar]
- a Yang P., Bassil B. S., Lin Z., Haider A., Alfaro-Espinoza G., Ullrich M. S., Silvestru C., Kortz U.. Organoantimony(III)-Containing Tungstoarsenates(III): From Controlled Assembly to Biological Activity. Chem.Eur. J. 2015;21:15600–15606. doi: 10.1002/chem.201502398. [DOI] [PubMed] [Google Scholar]; b Barsukova-Stuckart M., Piedra-Garza L. F., Gautam B., Alfaro-Espinoza G., Izarova N. V., Banerjee A., Bassil B. S., Ullrich M. S., Breunig H. J., Silvestru C., Kortz U.. Synthesis and Biological Activity of Organoantimony(III)-Containing Heteropolytungstates. Inorg. Chem. 2012;51:12015–12022. doi: 10.1021/ic301892s. [DOI] [PubMed] [Google Scholar]; c Yang P., Lin Z., Bassil B. S., Alfaro-Espinoza G., Ullrich M. S., Li M.-X., Silvestru C., Kortz U.. Tetra-Antimony(III)-Bridged 18-Tungsto-2-Arsenates(V), [(LSbIII)4(A-α-AsVW9O34)2]10– (L = Ph, OH): Turning Bioactivity On and Off by Ligand Substitution. Inorg. Chem. 2016;55:3718–3720. doi: 10.1021/acs.inorgchem.6b00107. [DOI] [PubMed] [Google Scholar]; d Yang P., Lin Z., Alfaro-Espinoza G., Ullrich M. S., Raţ C. I., Silvestru C., Kortz U.. 19-Tungstodiarsenate(III) Functionalized by Organoantimony(III) Groups: Tuning the Structure–Bioactivity Relationship. Inorg. Chem. 2016;55:251–258. doi: 10.1021/acs.inorgchem.5b02189. [DOI] [PubMed] [Google Scholar]; e Ma T., Yang P., Dammann I., Lin Z., Mougharbel A. S., Li M.-X., Adǎscǎliţei F., Mitea R., Silvestru C., Thorstenson C., Ullrich M. S., Cseh K., Jakupec M. A., Keppler B. K., Donalisio M., Cavalli R., Lembo D., Kortz U.. Tetra-(p-tolyl)antimony(III)-Containing Heteropolytungstates, [{(p-tolyl)SbIII}4(A-α-XW9O34)2] n− (X = P, As, or Ge): Synthesis, Structure, and Study of Antibacterial and Antitumor Activity. Inorg. Chem. 2020;59:2978–2987. doi: 10.1021/acs.inorgchem.9b03322. [DOI] [PubMed] [Google Scholar]
- a Llusar R., Sorribes I., Vicent C.. Electrospray Ionization Based Methods for the Generation of Polynuclear Oxo- and Hydroxo Group 6 Anions in the Gas-Phase. J. Cluster Sci. 2009;20:177–192. doi: 10.1007/s10876-008-0228-z. [DOI] [Google Scholar]; b Lin Z., Wang B., Cao J., Chen B., Xu C., Huang X., Fan Y., Hu C.. Controlled Synthesis of Polyoxopalladates, and Their Gas-Phase Fragmentation Study by Electrospray Ionization Tandem Mass Spectrometry. Eur. J. Inorg. Chem. 2013;2013:3458–3463. doi: 10.1002/ejic.201300372. [DOI] [Google Scholar]; c Cao J., Li C., Zhang Z., Xu C., Yan J., Cui F., Hu C.. Intriguing Role of a Quaternary Ammonium Cation in the Dissociation Chemistry of Keggin Polyoxometalate Anions. J. Am. Soc. Mass Spectrom. 2012;23:366–374. doi: 10.1007/s13361-011-0296-4. [DOI] [PubMed] [Google Scholar]; d Su P., Smith A. J., Warneke J., Laskin J.. Gas-Phase Fragmentation of Host-Guest Complexes of Cyclodextrins and Polyoxometalates. J. Am. Soc. Mass Spectrom. 2019;30:1934–1945. doi: 10.1007/s13361-019-02266-8. [DOI] [PubMed] [Google Scholar]
- a Quick A. J., Adams R.. ALIPHATIC ARSONIC AND ARSINIC ACIDS, AND ALIPHATIC-AROMATIC ARSINIC ACIDS. J. Am. Chem. Soc. 1922;44:805–816. doi: 10.1021/ja01425a014. [DOI] [Google Scholar]; b Simon A., Schumann H.-D.. Raman und infrarotspektroskopische Untersuchungen an Alkylderivaten der Arsensäure. III. Die Schwingungsspektren von Methan- und Äthanarsonsäure sowie von Natriumhydrogenmethanarsonat. Z. Anorg. Allg. Chem. 1973;398:145–156. doi: 10.1002/zaac.19733980207. [DOI] [Google Scholar]
- Lloyd N. C., Morgan H. W., Nicholson B. K., Ronimus R. S.. Substituted phenylarsonic acids; structures and spectroscopy. J. Organomet. Chem. 2008;693:2443–2450. doi: 10.1016/j.jorganchem.2008.04.033. [DOI] [Google Scholar]
- Manna P., Szücs D., Csupász T., Fekete A., Szikra D., Lin Z., Gáspár A., Bhattacharya S., Zulaica A., Tóth I., Kortz U.. Shape and Size Tuning of BiIII-Centered Polyoxopalladates: High Resolution 209Bi NMR and 205/206Bi Radiolabelling for Potential Pharmaceutical Applications. Inorg. Chem. 2020;59:16769–16782. doi: 10.1021/acs.inorgchem.0c02857. [DOI] [PubMed] [Google Scholar]
- a Bruker AXS Inc . APEX Suite of Crystallographic Software, APEX 3, Version 2015.5–2; Bruker AXS Inc.: Madison, Wisconsin, USA, 2015. [Google Scholar]; b Bruker AXS Inc . SAINT, Version 7.56a and SADABS Version 2008/1; Bruker AXS Inc.: Madison, Wisconsin, USA, 2008. [Google Scholar]
- a Sheldrick G. M.. SHELXT–Integrated space-group and crystal-structure determination. Acta Crystallogr. A. 2015;71:3–8. doi: 10.1107/S2053273314026370. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Dolomanov O. V., Bourhis L. J., Gildea R. J., Howard J. A. K., Puschmann H.. OLEX2: A complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009;42:339–341. doi: 10.1107/S0021889808042726. [DOI] [Google Scholar]; c Sheldrick G. M.. Crystal Structure Refinement with SHELXL. Acta Crystallogr. C Struct. Chem. 2015;71:3–8. doi: 10.1107/S2053229614024218. [DOI] [PMC free article] [PubMed] [Google Scholar]; d Bourhis L. J., Dolomanov O. V., Gildea R. J., Howard J. A. K., Puschmann H.. The anatomy of a comprehensive constrained, restrained refinement program for the modern computing environment - Olex2 dissected. Acta Crystallogr. Sect. A Found. Adv. 2015;71:59–75. doi: 10.1107/S2053273314022207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brown, I. D. ; Altermatt, D. . Bond-Valence Parameters Obtained from a Systematic Analysis of the Inorganic Crystal Structure Database. Acta Crystallogr. 1985, B41, 244–247. [Google Scholar]
- Elshamy S., Kuhnert N., El-Shazly M., Ziemah J., Handoussa H.. Comparative metabolomic study of twelve Acacia species by UHPLC-q-tof-ESI-MS coupled with chemometrics in correlation with antibacterial activity. Fitoterapia. 2025;181:106378. doi: 10.1016/j.fitote.2025.106378. [DOI] [PubMed] [Google Scholar]
- Ziemah J., Ullrich M. S., Kuhnert N.. Antibacterial Activity Potential of Industrial Food Production Waste Extracts against Pathogenic Bacteria: Comparative Analysis and Characterization. Foods. 2024;13:1902. doi: 10.3390/foods13121902. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sundar A., Bhattacharya S., Oberstein J., Ma X., Bassil B. S., Nisar T., Taffa D. H., Wark M., Wagner V., Kortz U.. Organically Functionalized Mixed-Valent Polyoxo-30-molybdate Wheel and Neutral Tetramolybdenum(V) Oxo Cluster. Inorg. Chem. 2022;61:11524–11528. doi: 10.1021/acs.inorgchem.2c01236. [DOI] [PubMed] [Google Scholar]
- Delcour A. H.. Outer membrane permeability and antibiotic resistance. Biochim. Biophys. Acta. 2009;1794:808–816. doi: 10.1016/j.bbapap.2008.11.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nikaido H.. Molecular Basis of Bacterial Outer Membrane Permeability Revisited. Microbiol. Mol. Biol. Rev. 2003;67:593–656. doi: 10.1128/MMBR.67.4.593-656.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- a Adimpong D. B., So̷rensen K. I., Thorsen L., Stuer-Lauridsen B., Abdelgadir W. S., Nielsen D. S., Derkx P. M. F., Jespersen L.. Antimicrobial Susceptibility of Bacillus Strains Isolated from Primary Starters for African Traditional Bread Production and Characterization of the Bacitracin Operon and Bacitracin Biosynthesis. Appl. Environ. Microbiol. 2012;78:7903–7914. doi: 10.1128/AEM.00730-12. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Jakobsen L., Sandvang D., Jensen V. F., Seyfarth A. M., Frimodt-Mo̷ller N., Hammerum A. M.. Gentamicin susceptibility in Escherichia coli related to the genetic background: problems with breakpoints. Clin. Microbiol. Infect. 2007;13:830–832. doi: 10.1111/j.1469-0691.2007.01751.x. [DOI] [PubMed] [Google Scholar]
- Gerebtzoff G., Li-Blatter X., Fischer H., Frentzel A., Seelig A.. Halogenation of Drugs Enhances Membrane Binding and Permeation. ChemBiochem. 2004;5:676–684. doi: 10.1002/cbic.200400017. [DOI] [PubMed] [Google Scholar]
- Rossi L. D., Rocchetti G., Lucini L., Rebecchi A.. Antimicrobial Potential of Polyphenols: Mechanisms of Action and Microbial Responses – A Narrative Review. Antioxidants. 2025;14:200–200. doi: 10.3390/antiox14020200. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.






